MFSD10 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	19 studies	21% ± 7%	Explore
CD8-positive, alpha-beta T cell	17 studies	23% ± 7%	Explore
ciliated cell	13 studies	34% ± 12%	Explore
CD4-positive, alpha-beta T cell	12 studies	20% ± 5%	Explore
mature NK T cell	12 studies	23% ± 5%	Explore
regulatory T cell	12 studies	18% ± 4%	Explore
gamma-delta T cell	12 studies	23% ± 4%	Explore
pericyte	11 studies	24% ± 7%	Explore
B cell	10 studies	20% ± 3%	Explore
endothelial cell of lymphatic vessel	10 studies	23% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	10 studies	25% ± 4%	Explore
endothelial cell	10 studies	22% ± 9%	Explore
type I pneumocyte	9 studies	27% ± 14%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	23% ± 5%	Explore
mucosal invariant T cell	9 studies	21% ± 3%	Explore
non-classical monocyte	8 studies	30% ± 16%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	23% ± 4%	Explore
epithelial cell	8 studies	39% ± 18%	Explore
fibroblast	8 studies	22% ± 7%	Explore
basal cell	8 studies	35% ± 16%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	7 studies	22% ± 4%	Explore
classical monocyte	7 studies	29% ± 14%	Explore
memory B cell	7 studies	20% ± 2%	Explore
T cell	6 studies	20% ± 2%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	21% ± 5%	Explore
club cell	6 studies	27% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell	6 studies	28% ± 7%	Explore
abnormal cell	6 studies	22% ± 9%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	27% ± 7%	Explore
smooth muscle cell	5 studies	21% ± 2%	Explore
hematopoietic precursor cell	4 studies	35% ± 13%	Explore
exhausted T cell	4 studies	26% ± 6%	Explore
type II pneumocyte	4 studies	30% ± 14%	Explore
neuron	4 studies	29% ± 14%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	27% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	24% ± 2%	Explore
pancreatic A cell	3 studies	17% ± 2%	Explore
conventional dendritic cell	3 studies	42% ± 16%	Explore
common myeloid progenitor	3 studies	38% ± 4%	Explore
hematopoietic stem cell	3 studies	21% ± 5%	Explore
lymphocyte	3 studies	22% ± 3%	Explore
myeloid cell	3 studies	26% ± 4%	Explore
progenitor cell	3 studies	32% ± 16%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	34% ± 14%	Explore
glutamatergic neuron	3 studies	37% ± 12%	Explore
dendritic cell	3 studies	41% ± 15%	Explore
T follicular helper cell	3 studies	18% ± 3%	Explore
T-helper 17 cell	3 studies	21% ± 5%	Explore
innate lymphoid cell	3 studies	21% ± 5%	Explore
connective tissue cell	3 studies	25% ± 6%	Explore
plasmacytoid dendritic cell	3 studies	19% ± 3%	Explore
double negative thymocyte	3 studies	23% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	10 studies	26% ± 11%	Explore
peripheral blood	10 studies	24% ± 10%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	3478.10	1445 / 1445	100%	73.12	183 / 183
ovary	100%	5408.31	180 / 180	100%	108.53	430 / 430
pancreas	100%	2370.11	328 / 328	100%	122.85	178 / 178
thymus	100%	6606.56	653 / 653	100%	94.29	604 / 605
uterus	100%	5525.23	170 / 170	100%	108.16	457 / 459
prostate	100%	5695.24	245 / 245	99%	114.75	498 / 502
skin	100%	3598.96	1808 / 1809	99%	103.98	468 / 472
intestine	100%	4081.09	966 / 966	99%	100.39	522 / 527
breast	100%	4866.44	459 / 459	99%	91.65	1103 / 1118
stomach	100%	3402.19	359 / 359	99%	80.36	282 / 286
kidney	100%	4768.71	89 / 89	99%	78.48	888 / 901
lung	100%	5468.57	578 / 578	99%	90.14	1138 / 1155
bladder	100%	4717.95	21 / 21	98%	128.08	496 / 504
brain	99%	3272.47	2626 / 2642	98%	57.83	694 / 705
adrenal gland	100%	2549.06	258 / 258	93%	40.03	213 / 230
liver	74%	868.18	168 / 226	48%	31.91	196 / 406
adipose	100%	4400.67	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	77.93	80 / 80
lymph node	0%	0	0 / 0	100%	108.74	29 / 29
spleen	100%	5721.39	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	76.40	45 / 45
ureter	0%	0	0 / 0	100%	109.79	1 / 1
blood vessel	100%	3622.61	1332 / 1335	0%	0	0 / 0
peripheral blood	99%	5217.59	920 / 929	0%	0	0 / 0
heart	99%	2060.15	852 / 861	0%	0	0 / 0
muscle	79%	966.65	635 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006915	Biological process	apoptotic process
GO_0043252	Biological process	sodium-independent organic anion transport
GO_0015904	Biological process	tetracycline transmembrane transport
GO_0031526	Cellular component	brush border membrane
GO_0030659	Cellular component	cytoplasmic vesicle membrane
GO_0005637	Cellular component	nuclear inner membrane
GO_0016020	Cellular component	membrane
GO_0008493	Molecular function	tetracycline transmembrane transporter activity
GO_0008514	Molecular function	organic anion transmembrane transporter activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	MFSD10
Protein name	Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein) Major facilitator superfamily domain containing 10
Synonyms	TETRAN
Description	FUNCTION: Probable organic anion transporter which may serve as a transporter for some non-steroidal anti-inflammatory drugs (NSAIDs) as well as other organic anions across the luminal membranes of renal proximal tubules at the final excretion step into the urine. .
Accessions	D6R9N3 ENST00000507555.1 ENST00000507272.5 ENST00000514800.5 D6RHV1 ENST00000329687.8 ENST00000503596.5 D6RA47 D6RIZ4 ENST00000355443.9 D6RE79 Q14728 ENST00000508221.5

MFSD10 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review